ibrutinib
abbvie,janssen
['$abbv', '$jnj']
$jnj $abbv #asco22: imbruvica keeps aggressive blood cancer at bay for 6+ years, but misses the mark in overall survival - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities